Pasithea Therapeutics Corp. (KTTA) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Pasithea Therapeutics Cor...

    NASDAQ: KTTA · Real-Time Price · USD
    0.79
    -0.01 (-0.75%)
    At close: Sep 05, 2025, 3:59 PM
    0.77
    -2.54%
    After-hours: Sep 05, 2025, 07:49 PM EDT

    Pasithea Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a 486.56K 15.06K
    Cost of Revenue
    		 649.03K 648.45K 113.19K 17.27K
    Gross Profit
    		 -649.03K -648.45K 373.36K -2.21K
    Operating Income
    		 -14.25M -15.98M -14.82M -4.51M
    Interest Income
    		 423.18K n/a n/a n/a
    Pretax Income
    		 -13.9M -15.51M -13.94M -2.17M
    Net Income
    		 -13.9M -15.96M -13.06M -2.17M
    Selling & General & Admin
    		 6.4M 7.88M 12.52M 4.51M
    Research & Development
    		 7.2M 8.1M 2.67M n/a
    Other Expenses
    		 n/a n/a 44.72K n/a
    Operating Expenses
    		 13.6M 15.98M 15.19M 4.51M
    Interest Expense
    		 n/a n/a 102.00 508.00
    Selling & Marketing Expenses
    		 n/a -7.87B 2.6M n/a
    Cost & Expenses
    		 14.25M 15.98M 15.3M 4.52M
    Income Tax Expense
    		 n/a n/a -879.97K 508.00
    Shares Outstanding (Basic)
    		 1.1M 1.26M 1.26M 1.15M
    Shares Outstanding (Diluted)
    		 1.1M 1.23M 1.26M 1.15M
    EPS (Basic)
    		 -12.69 -12.65 -10.34 -1.89
    EPS (Diluted)
    		 -12.69 -13.01 -10.34 -1.89
    EBITDA
    		 -13.26M -15.33M -12.58M -4.51M
    EBIT
    		 -13.9M -15.98M -12.59M -4.51M
    Depreciation & Amortization
    		 649.03K 648.45K 5.09K 1.38K

    Add to Watchlist